Cim Investment Management Inc Vertex Pharmaceuticals Inc Transaction History

Cim Investment Management Inc

$321 Million
Q2 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Sep 02, 2022	SELL	$234.96 - $292.55 $322,835 - $401,963	-1,374 Closed	0 $0
Q1 2022 May 17, 2022	SELL	$221.42 - $260.97 $1.45 Million - $1.71 Million	-6,570 Reduced 82.7%	1,374 $359,000
Q4 2021 May 19, 2022	SELL	$177.01 - $223.45 $1.14 Million - $1.44 Million	-6,459 Reduced 44.84%	7,944 $1.75 Million
Q4 2021 Feb 02, 2022	BUY	$177.01 - $223.45 $1.41 Million - $1.78 Million	7,944 Added 122.99%	14,403 $2.92 Million
Q3 2021 Nov 15, 2021	BUY	$181.39 - $202.99 $376,384 - $421,204	2,075 Added 47.33%	6,459 $1.17 Million
Q2 2021 Aug 13, 2021	BUY	$187.49 - $221.1 $500,785 - $590,558	2,671 Added 155.93%	4,384 $884,000
Q1 2021 May 20, 2021	SELL	$207.02 - $241.31 $12,214 - $14,237	-59 Reduced 3.33%	1,713 $368,000
Q4 2020 Feb 17, 2021	BUY	$207.01 - $276.09 $366,821 - $489,231	1,772 New	1,772 $419,000
Q1 2020 May 22, 2020	SELL	$199.77 - $247.81 $604,304 - $749,625	-3,025 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$166.23 - $187.09 $51,697 - $58,184	-311 Reduced 9.32%	3,025 $512,000
Q2 2019 Aug 08, 2019	BUY	$164.61 - $190.37 $20,740 - $23,986	126 Added 3.93%	3,336 $612,000
Q1 2019 May 13, 2019	BUY	$163.73 - $194.7 $266,061 - $316,387	1,625 Added 102.52%	3,210 $590,000
Q4 2018 Feb 05, 2019	SELL	$151.91 - $192.21 $9,874 - $12,493	-65 Reduced 3.94%	1,585 $263,000
Q3 2018 Nov 09, 2018	SELL	$167.73 - $192.74 $275,915 - $317,057	-1,645 Reduced 49.92%	1,650 $318,000
Q2 2018 Aug 07, 2018	SELL	$145.72 - $169.96 $13,697 - $15,976	-94 Reduced 2.77%	3,295 $560,000
Q1 2018 May 10, 2018	SELL	$151.6 - $177.13 $12,734 - $14,878	-84 Reduced 2.42%	3,389 $552,000
Q4 2017 Feb 13, 2018	BUY	$137.28 - $155.55 $476,773 - $540,225	3,473	3,473 $520,000

Others Institutions Holding VRTX

# of Institutions

1,716

Shares Held

225M

Call Options Held

1.19M

Put Options Held

1.56M

Capital World Investors Los Angeles, CA

26.7M
Shares

$13.4 Billion
2.1% of portfolio
Vanguard Group Inc Valley Forge, PA

23M
Shares

$11.5 Billion
0.21% of portfolio
Black Rock Inc. New York, NY

21.3M
Shares

$10.7 Billion
0.23% of portfolio
State Street Corp Boston, MA

11.7M
Shares

$5.89 Billion
0.24% of portfolio
Capital Research Global Investors Los Angeles, CA

8.54M
Shares

$4.29 Billion
0.9% of portfolio

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cim Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cim Investment Management Inc with notifications on news.

Account